BlackRock’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Sell |
5,470,374
-236,258
| -4% | -$881K | ﹤0.01% | 2969 |
|
|
2025
Q1 | $15.8M | Sell |
5,706,632
-36,850
| -0.6% | -$102K | ﹤0.01% | 3038 |
|
|
2024
Q4 | $31.8M | Buy |
5,743,482
+1,044,711
| +22% | +$5.79M | ﹤0.01% | 2711 |
|
|
2024
Q3 | $39.2M | Buy |
4,698,771
+578,263
| +14% | +$4.82M | ﹤0.01% | 2593 |
|
|
2024
Q2 | $28.1M | Buy |
4,120,508
+804,979
| +24% | +$5.48M | ﹤0.01% | 2734 |
|
|
2024
Q1 | $21.7M | Sell |
3,315,529
-93,449
| -3% | -$613K | ﹤0.01% | 2896 |
|
|
2023
Q4 | $22.1M | Buy |
3,408,978
+244,163
| +8% | +$1.58M | ﹤0.01% | 2903 |
|
|
2023
Q3 | $15.9M | Buy |
3,164,815
+26,286
| +0.8% | +$132K | ﹤0.01% | 3023 |
|
|
2023
Q2 | $27.5M | Buy |
3,138,529
+2,437,862
| +348% | +$21.3M | ﹤0.01% | 2776 |
|
|
2023
Q1 | $8.3M | Buy |
700,667
+401,229
| +134% | +$4.75M | ﹤0.01% | 3341 |
|
|
2022
Q4 | $3.05M | Buy |
299,438
+13,145
| +5% | +$134K | ﹤0.01% | 3872 |
|
|
2022
Q3 | $1.69M | Buy |
286,293
+136,765
| +91% | +$806K | ﹤0.01% | 4188 |
|
|
2022
Q2 | $371K | Sell |
149,528
-587,413
| -80% | -$1.46M | ﹤0.01% | 4774 |
|
|
2022
Q1 | $2.19M | Sell |
736,941
-8,594
| -1% | -$25.5K | ﹤0.01% | 4265 |
|
|
2021
Q4 | $5.27M | Buy |
745,535
+142,979
| +24% | +$1.01M | ﹤0.01% | 3911 |
|
|
2021
Q3 | $6.28M | Buy |
602,556
+164,952
| +38% | +$1.72M | ﹤0.01% | 3812 |
|
|
2021
Q2 | $5.37M | Buy |
437,604
+30,255
| +7% | +$371K | ﹤0.01% | 3785 |
|
|
2021
Q1 | $8.96M | Buy |
+407,349
| New | +$8.96M | ﹤0.01% | 3580 |
|